Abstract
Nitric oxide (NO.) and its reaction products are key players in the physiology and pathophysiology of inflammatory settings such as sepsis and shock. The consequences of the expression of inducible NO. synthase (iNOS, NOS-2) can be either protective or damaging to the liver. We have delineated two distinct hepatoprotective actions of NO.: the stimulation of cyclic guanosine monophosphate and the inhibition of caspases by S-nitrosation. In contrast, iNOS / NO. promotes hepatocyte death under conditions of severe redox stress, such as hemorrhagic shock or ischemia / reperfusion. Redox stress activates an unknown molecular switch that transforms NO., which is hepatoprotective under resting conditions, into an agent that induces hepatocyte death. We hypothesize that the magnitude of the redox stress is a major determinant for the effects of NO. on cell survival by controlling the chemical fate of NO.. To address this hypothesis, we have carried out studies in relevant in vivo and in vitro settings. Moreover, we have constructed an initial mathematical model of caspase activation and coupled it to a model describing some of the reactions of NO • in hepatocytes. Our studies suggest that modulation of iron, oxygen, and superoxide may dictate whether NO. is hepatoprotective or hepatotoxic.
Keywords: inflammatory inos, isoform, gene transcription, cytokines, apoptosis, rodent models, inflammation
Current Molecular Medicine
Title: Inflammatory Modulation of Hepatocyte Apoptosis by Nitric Oxide: In Vivo, In Vitro, and In Silico Studies
Volume: 4 Issue: 7
Author(s): Yoram Vodovotz, Peter K. M. Kim, Elife Zerrin Bagci, G. Bard Ermentrout, Carson C. Chow, Ivet Bahar and Timothy R. Billiar
Affiliation:
Keywords: inflammatory inos, isoform, gene transcription, cytokines, apoptosis, rodent models, inflammation
Abstract: Nitric oxide (NO.) and its reaction products are key players in the physiology and pathophysiology of inflammatory settings such as sepsis and shock. The consequences of the expression of inducible NO. synthase (iNOS, NOS-2) can be either protective or damaging to the liver. We have delineated two distinct hepatoprotective actions of NO.: the stimulation of cyclic guanosine monophosphate and the inhibition of caspases by S-nitrosation. In contrast, iNOS / NO. promotes hepatocyte death under conditions of severe redox stress, such as hemorrhagic shock or ischemia / reperfusion. Redox stress activates an unknown molecular switch that transforms NO., which is hepatoprotective under resting conditions, into an agent that induces hepatocyte death. We hypothesize that the magnitude of the redox stress is a major determinant for the effects of NO. on cell survival by controlling the chemical fate of NO.. To address this hypothesis, we have carried out studies in relevant in vivo and in vitro settings. Moreover, we have constructed an initial mathematical model of caspase activation and coupled it to a model describing some of the reactions of NO • in hepatocytes. Our studies suggest that modulation of iron, oxygen, and superoxide may dictate whether NO. is hepatoprotective or hepatotoxic.
Export Options
About this article
Cite this article as:
Vodovotz Yoram, Kim K. M. Peter, Bagci Zerrin Elife, Ermentrout Bard G., Chow C. Carson, Bahar Ivet and Billiar R. Timothy, Inflammatory Modulation of Hepatocyte Apoptosis by Nitric Oxide: In Vivo, In Vitro, and In Silico Studies, Current Molecular Medicine 2004; 4 (7) . https://dx.doi.org/10.2174/1566524043359944
DOI https://dx.doi.org/10.2174/1566524043359944 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Acute Effects of Neutrophil-Derived Oxidative Stress on Pulmonary Microvasculature
Current Respiratory Medicine Reviews Adenosine Receptors: New Therapeutic Targets for Inflammation in Diabetic Nephropathy
Inflammation & Allergy - Drug Targets (Discontinued) Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Proteome and Metabolome Alterations in Heart and Liver Indicate Compromised Energy Production During Sepsis
Protein & Peptide Letters Target-based Anti-angiogenic Therapy in Breast Cancer
Current Pharmaceutical Design Application of Decoy Oligonucleotides as Novel Therapeutic Strategy: A Contemporary Overview
Current Drug Discovery Technologies Peptide modules for overcoming barriers of nucleic acids transport to cells
Current Topics in Medicinal Chemistry Tailoring NO Donors Metallopharmaceuticals: Ruthenium Nitrosyl Ammines and Aliphatic Tetraazamacrocycles
Current Medicinal Chemistry Experimental Rodent Models of Vascular Dementia: A Systematic Review
CNS & Neurological Disorders - Drug Targets Proteomic Analysis of Liver Preservation Solutions Prior to Liver Transplantation
Current Proteomics An Update on “Selenium Containing Compounds from Poison to Drug Candidates: A Review on the GPx-like Activity”
Current Chemical Biology Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design
Current Topics in Medicinal Chemistry The Perils, Pitfalls and Opportunities of Using High Sensitivity Cardiac Troponin
Current Medicinal Chemistry Effects of Carnosine Plus Vitamin E and Betaine Treatments on Oxidative Stress in Some Tissues of Aged Rats
Current Aging Science Up-Regulation of TLR-4 in the Brain After Ischemic Kidney-Induced Encephalopathy in the Rat
CNS & Neurological Disorders - Drug Targets Heat Shock Proteins Protect Against Ischemia and Inflammation Through Multiple Mechanisms
Inflammation & Allergy - Drug Targets (Discontinued) Common Therapeutic Strategies for Diabetic Retinopathy and Glaucoma
Current Drug Therapy The Heart Metabolism: Pathophysiological Aspects in Ischaemia and Heart Failure
Current Pharmaceutical Design Recent Applications of Peanut Phytoalexins
Recent Patents on Food, Nutrition & Agriculture Prasugrel: A Novel Antiplatelet Therapy for Acute Coronary Syndromes
Recent Patents on Cardiovascular Drug Discovery